VALN

Valneva
VALN

9.54 USD
+0.80
9.15%
At close Updated Nov 26, 4:00 PM EST
Pre-market
After hours
9.55
+0.01
0.1%
1 day
9.15%
5 days
9.53%
1 month
3.02%
3 months
6.47%
6 months
49.53%
Year to date
102.12%
1 year
138.5%
5 years
-66.35%
10 years
-66.35%
 

About: Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.

Employees: 713

Healthcare Biotechnology
0
Funds holding %
of 7,476 funds
Explore Fund Trends
0
Analysts bullish %
of 1 analysts
See Analyst Outlook
0
Positive news %
of 7 articles
Check Journalist POV
Price charts implemented using Lightweight Charts™